DIBUCAINE OINTMENT

The Defense Logistics Agency awarded MR UNLIMITED, LLC (CAGE 3W8H0) a firm-fixed-price contract valued at $22.86 for the procurement of DIBUCAINE OINTMENT under NSN 6505-00-299-9535, with manufacturer part number NDC00536-1211-95 supplied by The Harvard Drug Group, L.L.C. The product is a 1 percent dibucaine ointment in a collapsible tube with a rectal applicator, intended for external and rectal use only, with each unit containing one ounce or 28 grams, stored at 15-30°C (59-86°F), and possessing a non-extendable 36-month Type I (Code Q) shelf life. The solicitation, SPE2DP-26-T-4079, issued on July 13, 2026, was processed as an automated simplified acquisition using the DLA Master Solicitation Revision 105 and closed for quotations on July 20, 2026, with award issued on July 23, 2026. Delivery is required within five days after award date, FOB destination, with zero variance allowed. The item must be packaged in commercial containers in compliance with MIL-STD-2073-1E and Special Packaging Instructions MPWNN00001, revised March 30, 1988, while all marking must conform to Medical Marking Standard No. 1, superseding MIL-STD-129. Inspection and acceptance occur at the destination in accordance with FAR 52.246-2, and government identification must be removed from any non-accepted supplies. Payment must be processed electronically through Wide Area Workflow (WAWF), with the contractor required to be registered on SAM.gov and WAWF.eb.mil, and submission of both invoice and receiving report is mandatory unless exempted. The contract includes numerous FAR and DFARS clauses amended by Deviation 2026-00038, covering system maintenance, small business representation, employment eligibility, trafficking in persons, safeguarding information systems, changes, subcontracts, and more, along with a specific deviation for hazardous material compliance under IP025. The awardee is subject to HUBZone price evaluation